ReviewInternational journal of legal medicine2026
Postmortem toxicological investigations in cases with an extended postmortem interval and advanced decomposition.
Review in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postmortem (PM) toxicological analysis and interpretation are complicated by PM redistribution, degradation and/or formation. Most existing knowledge on PM compound concentration changes is based on animal and human studies with a PM interval (PMI) up to a week. Consequently, there is limited knowledge of how concentrations change in cases with an extended PMI or advanced decomposition. In this narrative review we provide an overview of existing literature describing toxicological measurements in human tissue and bodily fluids with a PMI of 168 h (seven days) or more. After a literature search, the information on PMI, matrix, compound and decomposition was collected from 56 selected publications, the majority of which were case reports or case series. An overview is provided of investigated matrices and detected compounds across five PMI groups. Localized and confined bodily fluids, such as femoral blood and cardiac blood and vitreous humor, have been sampled up to four weeks PM, but are usually only available for several days PM. Collection and analysis of soft and hard tissues were described, identifying 147 different compounds in cases with PMI's up to ten years and beyond. Although the number of false negative results in these publications is unknown, these findings are in support of qualitative investigation of drug exposure in alternative matrices after an extended PMI. However, one should refrain from drawing conclusions regarding perimortem effects based on quantitative results. Toxicological findings should be considered supportive of those from pathological and crime scene investigations and interpreted as part of the death investigation.
Indexed as
Identifiers
42645515What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.